![John Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Evans
Verkställande Direktör på
BEAM THERAPEUTICS INC.
Förmögenhet: 38 M $ per 2026-05-31
Profil
John Evans is Chief Executive Officer at Beam Therapeutics, Inc. since 2024, also serving as CAO and Director there.
Mr. Evans is Chief Executive Officer at Blink Therapeutics, Inc. and Director at Orbital Therapeutics, Inc. Mr. Evans was Director at Verve Therapeutics, Inc. from 2018 to 2022 and Director at Prime Medicine, Inc. from 2019 to 2022.
Mr. Evans was Venture Partner at ARCH Venture Partners LLC from 2017 to 2021.
Mr. Evans was Vice President-Business Development & Operations at Agios Pharmaceuticals, Inc. from 2012 to 2017.
Mr. Evans was Senior Associate at McKinsey & Co., Inc. from 2005 to 2006.
Mr. Evans was Investor Relations Contact at Infinity Pharmaceuticals, Inc. Education includes graduate studies at the University of Pennsylvania, undergraduate studies at Yale University, and an MBA from The Wharton School of the University of Pennsylvania.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC. 1,12 % | 2026-04-01 | 1 150 205 ( 1,12 % ) | 38 M $ | 2026-05-31 |
Senaste nyheterna om John Evans
Aktiva positioner av John Evans
| Företag | Position | Start |
|---|---|---|
| BEAM THERAPEUTICS INC. | Verkställande Direktör | 2017-01-01 |
Blink Therapeutics, Inc.
 Blink Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platform to generate therapeutic and diagnostic monoclonal antibodies | Verkställande Direktör | - |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Direktör/Styrelseledamot | - |
Tidigare kända positioner av John Evans
| Företag | Position | Slut |
|---|---|---|
| PRIME MEDICINE, INC. | Direktör/Styrelseledamot | 2022-09-13 |
| VERE THER | Direktör/Styrelseledamot | 2022-08-04 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Privat kapitalinvesterare | 2021-03-31 |
| AGIOS PHARMACEUTICALS, INC. | Företagsledare/Principal | 2017-04-01 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Företagsledare/Principal | 2006-07-01 |
John Evanss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
84
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Blink Therapeutics, Inc.
Blink Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platform to generate therapeutic and diagnostic monoclonal antibodies | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Health Technology |
